Cargando…
Ectopic Expression of Rv0023 Mediates Isoniazid/Ethionamide Tolerance via Altering NADH/NAD(+) Levels in Mycobacterium smegmatis
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) accounts for nearly 1.2 million deaths per annum worldwide. Due to the emergence of multidrug-resistant (MDR) Mtb strains, TB, a curable and avertable disease, remains one of the leading causes of morbidity and mortality. Isoniazid (INH) i...
Autores principales: | Gupta, Shailesh Kumar, Angara, Rajendra Kumar, Yousuf, Suhail, Reddy, Chilakala Gangi, Ranjan, Akash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020754/ https://www.ncbi.nlm.nih.gov/pubmed/32117088 http://dx.doi.org/10.3389/fmicb.2020.00003 |
Ejemplares similares
-
Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation
por: Wang, Xu-De, et al.
Publicado: (2011) -
Consistency of standard laboratory strain Mycobacterium tuberculosis H(37)Rv with ethionamide susceptibility testing
por: Lakshmi, R., et al.
Publicado: (2012) -
Isoniazid Killing of Mycobacterium smegmatis NADH Pyrophosphatase Mutant at Single-Cell Level using Microfluidics and Time-Lapse Microscopy
por: Elitas, Meltem
Publicado: (2017) -
Increased Susceptibility of Mycobacterium tuberculosis to Ethionamide by Expressing PPs-Induced Rv0560c
por: Seo, Hoonhee, et al.
Publicado: (2022) -
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
por: Pillay, Samantha, et al.
Publicado: (2022)